alexa Systemically Administered Wound-homing Peptide Accelerates Wound Healing | 6807
ISSN: 2161-1076

Surgery: Current Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Systemically administered wound-homing peptide accelerates wound healing

International Conference and Exhibition on Surgery, Anesthesia & Trichology

Tero A.H. J?rvinen and Erkki Ruoslahti

Accepted Abstracts: Surgery Curr Res

DOI: 10.4172/2161-1076.S1.010

We have previously described two wound-homing peptides (J?rvinen and Ruoslahti, Am. J. Pathol. 2007) have used one of them (CARSKNKDC; dubbed CAR) to a wound-targeted an anti-scarring agent, CAR-decorin (J?rvinen and Ruoslahti, PNAS 2010). The CAR peptide without decorin had no effect in these experiments. We have now discovered that CAR, when given in doses 100 times higher than the amount of CAR delivered in the CAR-decorin experiments has an inherent wound healing- promoting activity. CAR penetrates into cells and tissues and is capable of inducing the transport of non-conjugated compounds from the blood into extravascular wound tissue in a manner similar to the recently identified CendR peptides (Sugahara et al., Science 2010). Cell migration is a rate-limiting step in wound closure. It has been shown that naturally occurring plasma->serum- >plasma transition controls wound closure, and that the serum generated by blood clotting drives the cell migration effecting wound closure. A wound is exposed to serum only for a short period of time, which could be limiting the regenerative potential. We hypothesized that CAR might be capable improving the availability to a wound of factors that promote healing. We gave mice with skin wounds twice a day intravenous injections of 60 μg of CAR peptide over 10 days. Three independent treatment experiments (n=24/group) in a mouse skin wound model have been conducted and show that wounds close (P > 0.001 for days 5 - 10) (Fig. 1) and re-epithelialize (P > 0.001 at day 5, 7 and 10) significantly faster in CAR-treated mice than in control groups. The mice remained healthy, and no obvious side effects were seen. A possible mechanism is that CAR helps deliver additional regenerative factors into the wounds. The CAR peptide may provide an entirely new way of enhancing wound healing, and perhaps tissue regeneration in general, that is systemic, yet target-specific, and non-toxic. Key Words: Homing peptide, systemic therapy, re-epithelialization, anti-scarring, cell penetrating peptide.
Leave Your Message 24x7